SE420565B - Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel - Google Patents

Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel

Info

Publication number
SE420565B
SE420565B SE7407462A SE7407462A SE420565B SE 420565 B SE420565 B SE 420565B SE 7407462 A SE7407462 A SE 7407462A SE 7407462 A SE7407462 A SE 7407462A SE 420565 B SE420565 B SE 420565B
Authority
SE
Sweden
Prior art keywords
intravascular administration
aid
suspension
solution
connection
Prior art date
Application number
SE7407462A
Other languages
English (en)
Swedish (sv)
Other versions
SE7407462L (sv
Inventor
U S E Rothman
B J Lindberg
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE7407462A priority Critical patent/SE420565B/xx
Priority to AU81647/75A priority patent/AU8164775A/en
Priority to DE19752524279 priority patent/DE2524279A1/de
Priority to US05/583,217 priority patent/US4124705A/en
Priority to GB24288/75A priority patent/GB1518121A/en
Priority to FR7517633A priority patent/FR2273555A1/fr
Priority to CA228,793A priority patent/CA1037950A/en
Priority to NL7506757A priority patent/NL7506757A/xx
Priority to JP50067730A priority patent/JPS6125689B2/ja
Publication of SE7407462L publication Critical patent/SE7407462L/
Publication of SE420565B publication Critical patent/SE420565B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/003—Crosslinking of starch
    • C08B31/006—Crosslinking of derivatives of starch

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7407462A 1974-06-06 1974-06-06 Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel SE420565B (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE7407462A SE420565B (sv) 1974-06-06 1974-06-06 Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel
AU81647/75A AU8164775A (en) 1974-06-06 1975-05-29 An agent for intravascular administration
DE19752524279 DE2524279A1 (de) 1974-06-06 1975-05-31 Mittel zur intravaskulaeren verabreichung und verfahren zu seiner herstellung
US05/583,217 US4124705A (en) 1974-06-06 1975-06-02 Agent for intravascular administration
GB24288/75A GB1518121A (en) 1974-06-06 1975-06-05 Agent for intravascular administration
FR7517633A FR2273555A1 (fr) 1974-06-06 1975-06-05 Agent d'administration intravasculaire
CA228,793A CA1037950A (en) 1974-06-06 1975-06-05 Agent for intravascular administration
NL7506757A NL7506757A (nl) 1974-06-06 1975-06-06 Middel voor intravasculaire toediening.
JP50067730A JPS6125689B2 (https=) 1974-06-06 1975-06-06

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7407462A SE420565B (sv) 1974-06-06 1974-06-06 Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel

Publications (2)

Publication Number Publication Date
SE7407462L SE7407462L (sv) 1975-12-08
SE420565B true SE420565B (sv) 1981-10-19

Family

ID=20321349

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7407462A SE420565B (sv) 1974-06-06 1974-06-06 Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel

Country Status (9)

Country Link
US (1) US4124705A (https=)
JP (1) JPS6125689B2 (https=)
AU (1) AU8164775A (https=)
CA (1) CA1037950A (https=)
DE (1) DE2524279A1 (https=)
FR (1) FR2273555A1 (https=)
GB (1) GB1518121A (https=)
NL (1) NL7506757A (https=)
SE (1) SE420565B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002772A1 (en) * 1983-12-21 1985-07-04 Schroeder Ulf Diagnostic and contrast agent

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5283960A (en) * 1976-01-01 1977-07-13 Pharmacia Ab Medicine for administrating in blood
DE2908437A1 (de) * 1979-03-05 1980-09-18 Fresenius Chem Pharm Ind Vernetzte hydroxyaethylstaerke
US4276885A (en) * 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4385046A (en) * 1980-12-15 1983-05-24 Minnesota Mining And Manufacturing Company Diagnostic radio-labeled polysaccharide derivatives
US4431626A (en) * 1981-05-27 1984-02-14 The Regents Of The University Of California Tc-99m Labeled carrier for imaging
FR2548902B1 (fr) * 1983-07-13 1986-04-11 Guerbet Sa Gel pour embolisation therapeutique
US5266333A (en) * 1985-03-06 1993-11-30 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone
US4680171A (en) * 1985-03-15 1987-07-14 William Shell Visualization of a bloodstream circulation with biodegradable microspheres
JPS62236839A (ja) * 1986-04-08 1987-10-16 Yoshiaki Motozato 架橋されたグルコマンナン球状粒子及びその製法
GB8801646D0 (en) * 1988-01-26 1988-02-24 Nycomed As Chemical compounds
US5420176A (en) * 1990-06-01 1995-05-30 Imarx Pharmaceutical Corp. Contrast media for ultrasonic imaging
US5948387A (en) * 1990-06-01 1999-09-07 Imarx Pharmaceutical Corp. Contrast media for ultrasonic imaging
ATE130517T1 (de) * 1990-08-08 1995-12-15 Takeda Chemical Industries Ltd Intravaskulär embolisierendes mittel mit gehalt an einem die angiogenesis hemmenden stoff.
US5603956A (en) * 1990-11-27 1997-02-18 Labopharm Inc. Cross-linked enzymatically controlled drug release
US5233995A (en) * 1991-11-21 1993-08-10 Sterling Winthrop Inc. Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods
ATE137668T1 (de) * 1992-07-24 1996-05-15 Labopharm Inc Vernetztes polyhydroxyl-material zur enzymatisch gesteuerten arzneistofffreisetzung
US5514379A (en) * 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
EP0830416B1 (en) * 1995-06-06 2005-08-31 C.R. Bard, Inc. Process for the preparation of crosslinked particles of water soluble polymers, the particles obtained and their use
US6214331B1 (en) 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7871637B2 (en) 1996-08-27 2011-01-18 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US6261320B1 (en) 1996-11-21 2001-07-17 Radiance Medical Systems, Inc. Radioactive vascular liner
US6491619B1 (en) 1997-01-31 2002-12-10 Endologix, Inc Radiation delivery catheters and dosimetry methods
US6458069B1 (en) 1998-02-19 2002-10-01 Endology, Inc. Multi layer radiation delivery balloon
US5782742A (en) * 1997-01-31 1998-07-21 Cardiovascular Dynamics, Inc. Radiation delivery balloon
US5993374A (en) * 1997-06-17 1999-11-30 Radiance Medical Systems, Inc. Microcapsules for site-specific delivery
US6048299A (en) * 1997-11-07 2000-04-11 Radiance Medical Systems, Inc. Radiation delivery catheter
US6149574A (en) * 1997-12-19 2000-11-21 Radiance Medical Systems, Inc. Dual catheter radiation delivery system
JP2002503530A (ja) 1998-02-19 2002-02-05 ラディアンス・メディカル・システムズ・インコーポレイテッド 薄膜照射線源
US6203778B1 (en) * 1998-12-08 2001-03-20 The Regents Of The University Of California Particulate radiopaque contrast agent for diagnostic imaging and microvascular characterization
EP1935421A1 (en) 2000-02-08 2008-06-25 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
US9080146B2 (en) 2001-01-11 2015-07-14 Celonova Biosciences, Inc. Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
US8834864B2 (en) 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
ATE503465T1 (de) 2004-10-25 2011-04-15 Celonova Biosciences Germany Gmbh Beladbare polyphosphazenhaltige teilchen für therapeutische und/oder diagnostische anwendungen sowie herstellungs- und verwendungsverfahren dafür
US20210299056A9 (en) 2004-10-25 2021-09-30 Varian Medical Systems, Inc. Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
US9114162B2 (en) 2004-10-25 2015-08-25 Celonova Biosciences, Inc. Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
US9107850B2 (en) 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
MX2008014847A (es) 2006-05-31 2009-04-30 Baxter Int Metodo para crecimiento interno en la celula dirigido y regeneracion controlada de los tejidos en la cirugia espinal.
TWI436793B (zh) 2006-08-02 2014-05-11 巴克斯特國際公司 快速作用之乾密封膠及其使用和製造方法
US8623842B2 (en) * 2006-09-27 2014-01-07 Hemostasis, Llc Hemostatic agent and method
ES2662647T3 (es) 2007-10-30 2018-04-09 Baxter International Inc. Uso de una biomatriz de colágeno biofuncional regenerativa para tratar defectos viscerales o parietales
CA2716872C (en) 2008-02-29 2015-02-10 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US9061087B2 (en) * 2008-03-04 2015-06-23 Hemostasis, Llc Method of making a hemostatic sponge wound dressing comprising subjecting the sponge to water vapor
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
HRP20150255T1 (hr) 2009-06-16 2015-05-08 Baxter International Inc. Hemostatiäśna spužva
CA2772023A1 (en) 2009-08-18 2011-02-24 Ben Gurion University Of The Negev Research And Development Authority System and method for analyzing imaging data
US8771258B2 (en) 2009-12-16 2014-07-08 Baxter International Inc. Hemostatic sponge
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
ES2682302T3 (es) 2010-06-01 2018-09-19 Baxter International Inc Proceso para la producción de composiciones hemostáticas secas y estables
AU2011260260B2 (en) 2010-06-01 2015-09-03 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
JP5973997B2 (ja) 2010-06-01 2016-08-23 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 乾燥した安定な止血用組成物を作製するためのプロセス
US9381269B2 (en) 2011-04-13 2016-07-05 Avent, Inc. Biosorbable wound treatment device, process for making, and method of using the same
WO2013053759A2 (en) 2011-10-11 2013-04-18 Baxter International Inc. Hemostatic compositions
MX346958B (es) 2011-10-11 2017-04-06 Baxter Int Composición hemostatica.
SG11201401878SA (en) 2011-10-27 2014-09-26 Baxter Int Hemostatic compositions
CN104159527B (zh) 2012-03-06 2017-04-12 弗罗桑医疗设备公司 包含止血糊剂的压力容器
RU2636240C2 (ru) 2012-06-12 2017-11-21 Ферросан Медикал Дивайсиз А/С Сухая гемостатическая композиция
JP6390873B2 (ja) 2013-06-21 2018-09-19 フェッローサン メディカル ディバイス エー／エス 減圧膨張させた乾燥組成物およびそれを保持するためのシリンジ
BR112016013322B1 (pt) 2013-12-11 2020-07-21 Ferrosan Medical Devices A/S métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit
BR112017007466B1 (pt) 2014-10-13 2021-03-02 Ferrosan Medical Devices A/S método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
CA2986981A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
JP6523510B1 (ja) 2018-03-30 2019-06-05 Ｊｘ金属株式会社 スパッタリングターゲット
EP4321182A3 (en) 2018-05-09 2024-05-29 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2626257A (en) * 1952-05-21 1953-01-20 Johnson & Johnson Medical dusting powder
NL252506A (https=) * 1959-06-12
SE372421B (https=) * 1968-04-01 1974-12-23 Minnesota Mining & Mfg
JPS5439444B2 (https=) * 1971-08-21 1979-11-28

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002772A1 (en) * 1983-12-21 1985-07-04 Schroeder Ulf Diagnostic and contrast agent

Also Published As

Publication number Publication date
FR2273555A1 (fr) 1976-01-02
SE7407462L (sv) 1975-12-08
DE2524279C2 (https=) 1990-07-12
DE2524279A1 (de) 1975-12-18
JPS517115A (https=) 1976-01-21
GB1518121A (en) 1978-07-19
FR2273555B1 (https=) 1978-10-06
US4124705A (en) 1978-11-07
AU8164775A (en) 1976-12-02
CA1037950A (en) 1978-09-05
NL7506757A (nl) 1975-12-09
JPS6125689B2 (https=) 1986-06-17

Similar Documents

Publication Publication Date Title
SE420565B (sv) Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel
SE411517B (sv) Inhalator for administration av pulverformiga substanser
HU173317B (hu) Sposob poluchenija anilidov furankarbonovojj kisloty i mikrobicidnye kompozicii soderzhahhie ikh aktivnymi agentami
SE7512996L (sv) Pediatrisk respirator
IL46919A0 (en) 16-oxygenated prostanoic acid derivatives and their preparation
NO154797C (no) Analogifremgangsmaate for fremstilling av cefalosporinforbindelser i den syn-isomere form eller ugiftige salter derav
DK407675A (da) Sugekateter
SE409856B (sv) Cyklopropankarboxylsyraestrar med insekticid och akaricid verkan
AT354604B (de) Blutfiltereinheit
IL45836A0 (en) Blood oxygenator
SE440595B (sv) Forfaraande for framstellning av mjuka dinatriumkromoglykatpelletkulor for inhalering
SE7510755L (sv) Kateteradapter
SE393138B (sv) Forfarande for blekning av cellulosa med en syre innehallande gas i nervaro av natriumbikarbonat
GB1445964A (en) Diagnostic agent for the detection of glucose in urine
DK625174A (da) Respirationskateter
SE383046B (sv) Anordning for indikering av ett foremals legesforendringar
SE401182B (sv) Furanhydroxamsyraderivat med fungicid verkan
ZA75179B (en) New arylpiperazine derivatives of adenine and the preparation thereof
SE431204B (sv) Forfarande for framstellning av n?722-naftalensulfonyl-l-argininestrar och -amider eller farmaceutiskt accepterbara syraadditionssalter derav
IT1036193B (it) Respiratore pediatrico
SE423236B (sv) Forfarande for framstellning av natriumsalter av amoxicillin
SE413280B (sv) Saett vid tillverkning av ett aetbart korvskinn av kollagen
BE827452A (nl) Bereiding van gemodificeerde polyolen
SE7509897L (sv) Basiskt substituerade 3-sulfamoylbensoesyraderivat och forfarande for deras framstellning
FR2295042A1 (fr) Agents ignifugeants phosphores utilisables dans la preparation de polyurethannes

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7407462-6

Effective date: 19940710

Format of ref document f/p: F